City: Campinas
See other companies with research projects supported by PIPE ProgramProstate cancer is a neoplasm of high incidence, prevalence and mortality in the world and many patients develop metastatic disease that becomes resistant to conventional antiandrogen therapies. Such patients are classified as having metastatic castration resistant prostate cancer (mCPRC). At this stage of the disease, there are few therapeutic options, and the survival of these patients …
The last decade has witnessed significant advances in the field of nuclear medicine therapy in Brazil with the approval of Lu-177 (for neuroendocrine tumors), Y-90 (for radioembolization) and recently Ra-223 (for bone metastases of prostate cancer). However, there is a great need for additional therapeutic options for patients with metastatic soft tissue prostate cancer. Based on the high…
| 2 / 2 | Completed research grants |
| Associated processes | |
Carregando Filtros. Aguarde...
Left-click and hold. Drag the cursor on the map until you see the view you want.
Select year: |
Show years by sequential order |